Medishine Pharmaceuticals Profile
Key Indicators
- Authorised Capital ₹ 8.14 M
as on 04-01-2025
- Paid Up Capital ₹ 8.06 M
as on 04-01-2025
- Company Age 5 Year, 5 Months
- Last Filing with ROC 31 Mar 2021
- Open Charges ₹ 5.43 M
as on 04-01-2025
- Revenue 200.36%
(FY 2021)
- Profit 338.33%
(FY 2021)
- Ebitda 217.34%
(FY 2021)
- Net Worth 223.96%
(FY 2021)
- Total Assets 309.53%
(FY 2021)
About Medishine Pharmaceuticals
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2021. It's a company limited by shares with an authorized capital of Rs 8.14 M and a paid-up capital of Rs 8.06 M.
The company currently has active open charges totaling ₹5.43 M.
Luit Barman and Navanil Barua serve as directors at the Company.
- CIN/LLPIN
U24304AS2019PTC019409
- Company No.
019409
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
31 Jul 2019
- Date of AGM
23 Nov 2021
- Date of Balance Sheet
31 Mar 2021
- Listing Status
Unlisted
- ROC Code
Roc Shillong
Industry
Company Details
- Location
Kamrup, Assam, India
- Telephone
- Email Address
- Website
- Social Media
Who are the key members and board of directors at Medishine Pharmaceuticals?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Luit Barman  | Director | 31-Jul-2019 | Current |
| Navanil Barua | Director | 07-Sep-2019 | Current |
Financial Performance of Medishine Pharmaceuticals.
Medishine Pharmaceuticals Private Limited, for the financial year ended 2021, experienced significant growth in revenue, with a 200.36% increase. The company also saw a substantial improvement in profitability, with a 338.33% increase in profit. The company's net worth Soared by an impressive increase of 223.96%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Medishine Pharmaceuticals?
In 2021, Medishine Pharmaceuticals had a promoter holding of 95.07% and a public holding of 4.93%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 08 Dec 2021 | ₹2.00 M | Open |
Hdfc Bank Limited Creation Date: 04 May 2021 | ₹1.71 M | Open |
Hdfc Bank Limited Creation Date: 04 May 2021 | ₹1.71 M | Open |
How Many Employees Work at Medishine Pharmaceuticals?
Unlock and access historical data on people associated with Medishine Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Medishine Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Medishine Pharmaceuticals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
